Femasys Inc is trading 5.7% down at $4.95 as investors digest a recent 1-for-20 reverse stock split and a significant reduction in Wall Street’s average 12-month price target.
- The new consensus target of $3.23 sits well below the current post-split price, which may pressure sentiment and trigger further downside.
- The decline follows a massive rally from sub-$1 levels earlier this month, prompting some traders to engage in profit-taking.